¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸ Echo Seoul & Cardiac Imaging 2021 (1ÀÏÂ÷) : 2021-09-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸ Echo Seoul & Cardiac Imaging 2021 (1ÀÏÂ÷) : 2021-09-11
±³À°ÀÏÀÚ : 2021-09-11
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : Echo Seoul & Cardiac Imaging 2021 (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸  
´ã´çÀÚ : ¿î¿µ»ç¹«±¹
¿¬¶ôó : 02-6002-1391  
À̸ÞÀÏ : echo@echoseoul.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í °³¿øÀÇ, Àü¹®ÀÇ : 10¸¸¿ø / ÀüÀÓÀÇ, ±ºÀÇ°ü, °øÁߺ¸°ÇÀÇ : 7¸¸¿ø / Àü°øÀÇ ¹× ±âŸ : 4¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-11 ±×·£µåº¼·ë 08:30~08:35 Opening remark  ÇÏÁ¾¿ø(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-11 ±×·£µåº¼·ë 08:35~08:45 Cases for discussion  ±è´ë¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 08:45~09:00 Echo: Strength and weakness for diagnosis and follow-up  À±¿¬ÀÌ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 09:00~09:15 CMR: Strength and weakness for diagnosis and follow-up  ±è¼º¸ñ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 09:15~09:30 Nuclear Imaging: Strength and weakness for diagnosis and follow-up  ÃÖÁØ¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 09:30~09:45 Genetics and biomakers beyond imaging  ÃÖÀÇ¿µ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-11 ±×·£µåº¼·ë 09:45~10:00 Panel Discussion  ¹Úöȯ/±è¹ÌÁ¤/À̽¾Æ(¿¬¼¼ÀÇ´ë/°¡Å縯ÀÇ´ë/¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:00~10:15 Are you really following the guidelines in clinical practice?  Sherif F. Nagueh(Houston Methodist) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:15~10:30 How detailed should the left atrium be examined?  Jae K. Oh(Mayo Clinic) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:30~10:45 When diastolic stress test is particularly useful?  ÇÏÁ¾¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 10:45~11:00 GLS, myocardial work imaging and diastolic function  Otto A. Smiseth(Oslo Univ. Hosp.) 
Åä·Ð 09-11 ±×·£µåº¼·ë 11:00~11:15 Panel Discussion  ±è¼ºÈ¯/±èÇüÀ±/Á¤ÀÎÇö(°í·ÁÀÇ´ë/Àü³²ÀÇ´ë/¿¬¼¼ÀÇ´ë¿ëÀÎ) 
È޽Ġ09-11 ±×·£µåº¼·ë 11:15~11:35 break  () 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 11:35~11:50 Diastolic function in patients with atrial fibrillation  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 11:50~12:05 Diastolic function in patients with mitral valve disease  ¹Ú¼ºÁö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 12:05~12:20 Diastolic function in patients with hypertrophic cardiomyopathy  ±èÇü°ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 12:20~12:35 Diastolic function in patients with fraility and sarcopenia  Kazuhiro Yamamoto(Tottori Univ.) 
Åä·Ð 09-11 ±×·£µåº¼·ë 12:35~12:50 Panel Discussion  º¯¿µ¼·/±è¹Ì³ª/±è¼º¾Ö(ÀÎÁ¦ÀÇ´ë/°í·ÁÀÇ´ë/ÇѸ²ÀÇ´ë) 
½Ä»ç 09-11 ±×·£µåº¼·ë 12:50~13:50 Á¡½É½Ä»ç  () 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 13:50~14:10 Special Lecture  ¼Õ´ë¿ø(¼­¿ï¿øÇÏÆ®³»°ú) 
Åä·Ð 09-11 ±×·£µåº¼·ë 14:10~14:20 Cases for Discussion  ¼­Áö¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 14:20~14:35 How to define MR with uncertain etiolgy or ambiguous severity  Á¤Çؾï(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 14:35~14:50 Natural history and outcomes of MR using large data sets  À̽ÂÇ¥(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 14:50~15:05 Echo for clinical trials: MR and chambers  °­´öÇö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 15:05~15:20 When to intervene? LV systolic dimension, LVEF, vs. LV strain  Á¶±¸¿µ(¼­¿ïÀÇ´ë) 
Åä·Ð 09-11 ±×·£µåº¼·ë 15:20~15:35 Panel Discussion  ¼ÕÀϼ®/³ªÁø¿À/Á¤ÇöÁÖ(°æÈñÀÇ´ë/°í·ÁÀÇ´ë/ÇѾçÀÇ´ë) 
È޽Ġ09-11 ±×·£µåº¼·ë 15:35~15:50 break  () 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 15:50~16:05 Properties, thrombogenecity, and durability of prosthetic valves  ÀÌ»è(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 16:05~16:20 2D/3D echo for patients with elevated prosthetic valve pressure gradient  ÀÌ»ç¹Î(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 16:20~16:35 Cardiac CT for patients with elevated prosthetic valve pressure gradient  ¼­¿µÁÖ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 16:35~16:50 Nuclear imaging for patients with elevated prosthetic valve pressure gradient  ÆØÁøö(¼­¿ïÀÇ´ë) 
Åä·Ð 09-11 ±×·£µåº¼·ë 16:50~17:05 Panel Discussion  È²¼ºÈ£/½Å¼ºÈñ/³²Á¾È£(°í·ÁÀÇ´ë/ÀÎÇÏÀÇ´ë/¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:05~17:15 Case 1: DCM with moderate AR vs. severe AR with LVD  Á¶µ¿Çõ(¿¬¼¼ÀÇ´ë¿øÁÖ) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:15~17:25 Case 2: DCM with moderate AS vs. severe AS with LVD  È²ÀÎâ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:25~17:40 Myocardial remodeling and reverse remodeling in AV disease  ±è´ëÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-11 ±×·£µåº¼·ë 17:40~17:55 CT/CMR for differential diagnosis and predicting reverse remodeling  È«À¯Áø(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-11 ±×·£µåº¼·ë 17:55~18:10 Panel Discussion  ÃÖÀçÇõ/À̼ö¿¬/ÀÌ»óÀç(ÇѸ²ÀÇ´ë/¼¼Á¾º´¿ø/¿ø±¤´ëÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸ Echo Seoul & Cardiac Imaging 2021 (1ÀÏÂ÷) : 2021-09-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Çѱ¹È£½ºÇǽº¡¤¿ÏÈ­ÀÇ·áÇÐȸ 2021³â Ã߰迬¼ö°­Á : 2021-09-11
´ÙÀ½±Û (¿Â¶óÀÎ) 2021³â ±¹Á¦¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2021-09-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 70 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 53 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 43 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 43 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 40 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 21 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 42 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 30 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 27 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷